Repatha (evolocumab)

Do You Qualify?

Income Limits (400% FPL)

Calculated based on 400% of 2025 FPL. Medicare Part D patients must meet additional criteria.

Based on 2025 HHS Federal Poverty Level guidelines.

# Getting Repatha (Evolocumab) at Low or No Cost Through the Amgen Safety Net Foundation

A Guide Prepared by RX Advantages

---

Who Qualifies for the Amgen Safety Net Foundation?

If you need Repatha (evolocumab) but cannot afford it, the Amgen Safety Net Foundation may be able to provide it at little or no cost. This program is designed for patients who are uninsured or underinsured and meet income guidelines. For a single person, your annual household income must be at or below $60,240 to qualify. If you have insurance that does not adequately cover Repatha — including certain Medicare Part D plans — you may still be eligible. Eligibility is based on your income, household size, and insurance status, and is determined entirely by Amgen. Most patients who qualify receive their medication shipped directly to their home.

---

About Repatha (Evolocumab)

Repatha (evolocumab) is a prescription injectable medication made by Amgen. It belongs to a drug class called PCSK9 inhibitors. Repatha is FDA-approved to treat adults with hyperlipidemia (high cholesterol), Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH). It is also approved to reduce the risk of certain cardiovascular events in adults with established cardiovascular disease. Without insurance or financial assistance, Repatha can cost several hundred to several thousand dollars per month, putting it out of reach for many patients. The Amgen Safety Net Foundation exists to help bridge that gap for qualifying individuals.

---

Income Eligibility: Full Breakdown

The Amgen Safety Net Foundation uses income thresholds set at 400% of the 2025 Federal Poverty Level (FPL). Your household size determines the maximum income allowed. The current limits are:

| Household Size | Max Annual Income |

|---|---|

| 1 person | $60,240 |

| 2 persons | $81,760 |

| 3 persons | $103,280 |

| 4 persons | $124,800 |

For households larger than four people, income limits increase further — contact the program directly at (888) 762-6436 to confirm the threshold for your household size.

Your income is typically verified using your most recent federal tax return (Form 1040 or W-2), or three consecutive months of recent pay stubs if you have not yet filed taxes for the prior year. Self-employed applicants may need to provide additional documentation.

If your income is above the limit for your household size, you may not qualify for free medication through this program. However, there are other options available, which are covered in the "Alternatives" section below. Do not assume you are disqualified without checking — income calculations can sometimes include deductions or adjustments.

---

Insurance Requirements Explained

Understanding how your insurance affects eligibility is important before you apply.

---

Step-by-Step: How to Apply

Follow these steps to apply for free Repatha through the Amgen Safety Net Foundation:

1. Gather your documents before you start. You will need: a completed application form (with both a patient section and a prescriber section), proof of income (Form 1040, W-2, or three months of pay stubs), and a current valid prescription for Repatha from your doctor.

2. Choose your application method. You can apply online, by phone, or by fax.

- Online: Visit https://www.amgensafetynetfoundation.com/ to start your application directly on the program website.

- By phone: Call (888) 762-6436 to apply with the help of a program representative. This is a good option if you have questions or need help completing the form.

- By fax: Complete the application form and fax it with your supporting documents to (866) 549-7239.

3. Have your prescriber complete their section. The application includes a section your doctor or their office staff must fill out. Coordinate with your prescriber's office early, as this step can sometimes cause delays.

4. Submit your income documentation along with the completed application, using whichever method you chose above.

5. Watch for confirmation. After submission, the program typically processes applications within 2 to 3 business days. You or your prescriber will be notified of the decision.

---

What to Expect: Timeline and Delivery

After you submit your application, the Amgen Safety Net Foundation typically processes it within 2 to 3 business days. You will receive confirmation of approval or a request for additional information. Once approved, Repatha is shipped directly to your home — you do not need to pick it up at a pharmacy. Make sure your mailing address is current and accurate on your application. Your enrollment is not permanent. The program requires annual reauthorization, meaning you will need to reapply and reconfirm your eligibility each year. Watch for renewal notices from the foundation so your supply is not interrupted.

---

Alternatives If You Don't Qualify

If you do not meet the eligibility requirements for the Amgen Safety Net Foundation, you still have options.

1. Biosimilars: There are currently no FDA-approved biosimilar versions of Repatha (evolocumab) available in the United States, so this is not an option at this time.

2. Manufacturer savings card for insured patients: If you have commercial (private) insurance, Amgen offers a Repatha Copay Card that may reduce your out-of-pocket costs significantly. You can learn more and enroll at https://www.repatha.com/repatha-copay-card. Note that this card is generally not available to Medicare or Medicaid patients.

3. State Pharmaceutical Assistance Programs (SPAPs): Many states offer programs that help residents pay for prescription drugs, particularly for seniors or people with disabilities. Search for your state's program through your state health department website.

4. NeedyMeds.org: This free database at https://www.needymeds.org lists hundreds of patient assistance programs, discount drug cards, and other cost-reduction options. It is a useful starting point if you need help exploring all available resources.

---

*This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Amgen. Program terms may change — verify current requirements at [https://www.repatha.com/cholesterol/savings](https://www.repatha.com/cholesterol/savings) before applying.*

---